International Registry on Cholangiocarcinoma Treatment

NCT01920503 · clinicaltrials.gov ↗

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma

Interventions

DRUG: Doxorubicin

Sponsor

International Group of Endovascular Oncology